日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Long-Term Treatment With Ocrelizumab in Patients With Early-Stage Relapsing MS: Nine-Year Data From the OPERA Studies Open-Label Extension

奥瑞珠单抗治疗早期复发型多发性硬化症患者的长期疗效:OPERA 研究开放标签扩展研究的九年数据

Cerqueira, João J; Berthele, Achim; Cree, Bruce A C; Filippi, Massimo; Pardo, Gabriel; Pearson, Owen R; Traboulsee, Anthony; Ziemssen, Tjalf; Vollmer, Timothy; Bernasconi, Corrado; Mandel, Corey R; Kulyk, Inessa; Chognot, Cathy; Raposo, Catarina; Schneble, Hans-Martin; Thanei, Gian-Andrea; Incera, Elodie; Havrdová, Eva K